The primary advantage to contracting with BBC is the high quality and cost-efficient primary market research, as well as strategic analysis that is available in a timely fashion. BBC prides itself on its extensive industry contact network, routine market monitoring efforts, and database models, which allow it to deliver first-rate, professional analyses in an expeditious manner. BBC has 30 years experience monitoring the In Vitro Diagnostic Test Products market across laboratory systems, diabetes care, molecular diagnostics (nucleic acid testing), and point-of-care testing (near-patient testing). As more specific diagnostic and metabolism markers have been discovered, BBC has augmented its capabilities in the area of pharmacogenomics (theranostics).
Due to BBC's vast market knowledge, the consultants are able to respond to many follow-up questions without an extensive and time consuming secondary study. Moreover, clients receive up to date notification and analysis of industry and market specific events through BBC's fax/e-mail alert services. As part of the service, the consultants prepare an immediate summary and analysis of critical announcements and industry developments, which is available to the client within a day of the event.
The wide reaching nature of BBC's capabilities allow the consultants to support the client's needs, stretching across business planning/forecasting, new product development, due diligence, competitive intelligence, and general market monitoring.
All of BBC's work is covered by mutual non-disclosure agreements to protect the client's interests. BBC prides itself on its integrity and discretion in dealing with confidential information acquired in conjunction with its client market research efforts.